Literature DB >> 12176964

Lessons learned from recent cardiovascular clinical trials: Part II.

David L DeMets1, Robert M Califf.   

Abstract

Mesh：

Year:  2002        PMID： 12176964     DOI： 10.1161/01.cir.0000023220.26465.89

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

Review 1.  The challenges of conducting clinical endpoint studies.

Authors:  Jonathan L Isaacsohn; Tiffany A Khodadad; Catherine Soldano-Noble; Jeffrey D Vest
Journal:  Curr Atheroscler Rep       Date:  2003-01       Impact factor: 5.113

2.  Exploring the ethical and regulatory issues in pragmatic clinical trials.

Authors:  Robert M Califf; Jeremy Sugarman
Journal:  Clin Trials       Date:  2015-09-15       Impact factor: 2.486

3.  Nutrition intervention to decrease symptoms in patients with advanced heart failure.

Authors:  Terry A Lennie; Debra K Moser; Martha J Biddle; Darlene Welsh; Geza G Bruckner; D Travis Thomas; Mary Kay Rayens; Alison L Bailey
Journal:  Res Nurs Health       Date:  2013-01-17       Impact factor: 2.228

Review 4.  Protein kinase C, an elusive therapeutic target?

Authors:  Daria Mochly-Rosen; Kanad Das; Kevin V Grimes
Journal:  Nat Rev Drug Discov       Date:  2012-12       Impact factor: 84.694

5.  The child and adolescent psychiatry trials network (CAPTN): infrastructure development and lessons learned.

Authors:  Mark Shapiro; Susan G Silva; Scott Compton; Allan Chrisman; Joseph DeVeaugh-Geiss; Alfiee Breland-Noble; Douglas Kondo; Jerry Kirchner; John S March
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2009-03-25       Impact factor: 3.033

6.  A third trial oversight committee: Functions, benefits and issues.

Authors:  J Athene Lane; Carrol Gamble; William J Cragg; Doreen Tembo; Matthew R Sydes
Journal:  Clin Trials       Date:  2019-10-30       Impact factor: 2.486
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.